Toyonaka, Japan

Hiroshi Hosono


Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Osaka, JP (1997)
  • Toyonaka, JP (2004)

Company Filing History:


Years Active: 1997-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Genius of Hiroshi Hosono: A Look into His Contributions

Introduction

Hiroshi Hosono is a distinguished inventor based in Toyonaka, Japan. With an impressive portfolio comprising two notable patents, he has made significant contributions to the field of chemical sciences, particularly in the area of organic chemistry.

Latest Patents

Hiroshi Hosono's latest patents include pivotal innovations such as "Acylhydrazine derivatives, their production and use" and "Production of optically active triazole compounds and their intermediates." These patents detail a complex compound represented by the formula (V), which includes features such as halogenated phenyl groups and various hydrocarbon residues. Additionally, the patents describe methods for preparing these compounds, ultimately providing an optically active intermediate for producing optically active triazole compounds.

Career Highlights

Hiroshi Hosono works for Takeda Chemical Industries, Inc., a renowned pharmaceutical company committed to advancing healthcare through innovative products. His expertise in chemistry has driven numerous breakthroughs that underscore the importance of research and development in the pharmaceutical industry.

Collaborations

Throughout his career, Hiroshi has collaborated with esteemed coworkers, including Katsumi Itoh and Akihiro Tasaka. Together, they have combined their skills and knowledge to enhance the potential of their research projects and drive forward the innovations emerging from Takeda Chemical Industries.

Conclusion

Hiroshi Hosono's work exemplifies the spirit of innovation in the field of chemistry. His patents not only enhance our understanding of organic compounds but also pave the way for future advancements in pharmaceutical applications. As he continues his journey at Takeda Chemical Industries, the scientific community eagerly anticipates his next breakthrough.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…